Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancerWilliam Greenhalf, John P. Neoptolemos, Daniel H. Palmer et al.|British Journal of Cancer|2018Cited by 34
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNAKaren Aughton, William Greenhalf, Nils Elander et al.|Cancers|2021Cited by 14